Search Result "glutamatergic agents"


Review Article

Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants

Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 35-46
Author(s): Roger A. Kroes, Carol L. Nilsson

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 219-238
Author(s): Felice Iasevoli,Carmine Tomasetti,Elisabetta F. Buonaguro,Andrea de Bartolomeis

The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 16-25
Author(s): Alberto C.S. Costa

Review Article open access plus

Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model

Journal: Current Pharmaceutical Biotechnology
Volume: 19 Issue: 4 Year: 2018 Page: 293-307
Author(s): Moritz Haaf,Gregor Leicht,Stjepan Curic,Christoph Mulert

Editorial free to download

Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine

Journal: Current Psychopharmacology
Volume: 6 Issue: 2 Year: 2017 Page: 89-93
Author(s): Uriel Heresco-Levy,Andrea R. Durrant

Non-Antidepressant Pharmacological Treatment of Obsessive Compulsive Disorder: A Comprehensive Review

Journal: Current Clinical Pharmacology
Volume: 10 Issue: 2 Year: 2015 Page: 97-111
Author(s): Pierre Abdel-Ahad,Francois Kazour

Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1 Issue: 2 Year: 2002 Page: 215-225
Author(s): Darryle D. Schoepp, Gerard J. Marek

Halogenated Derivatives of Aromatic Amino Acids Exhibit Balanced Antiglutamatergic Actions: Potential Applications for the Treatment of Neurological and Neuropsychiatric Disorders

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 1 Issue: 3 Year: 2006 Page: 261-270
Author(s): Anatoly E. Martynyuk, Christoph N. Seubert, Viktor Yarotskyy, Alexander V. Glushakov, Nikolaus Gravenstein, Colin Sumners, Donn M. Dennis

Glutamate and Psychosis Risk

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 466-478
Author(s): Alice Egerton, Paolo Fusar-Poli, James M. Stone

Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 5 Year: 2010 Page: 502-515
Author(s): Xavier Lopez-Gil, Francesc Artigas, Albert Adell

Previous   Next

Go To   Results 11 - 20 of 1405

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy